Severe Penile Lesion with Chronic Hypopigmented Patches and Environmental Exposure
This patient most likely has lichen sclerosus (LS) with a severe penile lesion requiring urgent biopsy to exclude malignant transformation, followed by treatment with potent topical corticosteroids or surgical intervention depending on histology.
Diagnostic Approach
The clinical picture of chronic pruritic hypopigmented patches on the penis strongly suggests lichen sclerosus, particularly given the description of a "worst lesion" which raises concern for complications. The cat-infested, dilapidated environment is likely a red herring—while cutaneous larva migrans presents with serpiginous pruritic lesions 1, it doesn't cause chronic hypopigmented patches and wouldn't explain a severe focal penile lesion.
Critical First Step: Biopsy
A biopsy must be performed immediately if there is: 2
- A persistent area of hyperkeratosis, erosion, or erythema
- New warty or papular lesions
- Any lesion highly suspicious of squamous cell carcinoma
- Failure to respond to adequate treatment
- Any suspicion of neoplastic change
The "worst lesion" descriptor suggests possible progression to penile intraepithelial neoplasia (PeIN) or squamous cell carcinoma, which occurs in untreated or poorly controlled LS 2. Multiple mapping biopsies may be required if there is extensive abnormality 2.
Treatment Algorithm
If Biopsy Shows Benign LS:
First-line treatment is potent topical corticosteroids (e.g., clobetasol propionate 0.05%) applied to affected areas 2. Common sites in adult males include the glans penis, coronal sulcus, frenulum, and prepuce 2.
Key application considerations: 2
- Ensure adequate amount applied to correct site
- If phimosis is present, introduce topical steroid using cotton wool bud
- If phimosis prevents application entirely, refer to urology for circumcision
- In obese patients with buried penis, address obesity as topical treatment will fail
If Biopsy Shows PeIN or Invasive Cancer:
Urgent referral to specialist urologist is mandatory 2. Treatment options depend on staging:
For early-stage disease (Tis, Ta, T1a): 3
- Organ-sparing surgery is preferred when feasible
- Laser therapy shows 69.4% 5-year recurrence-free rate
- Brachytherapy achieves 78.6% 5-year recurrence-free rate for tumors <4 cm
- Standard excision requires negative surgical margins with clinically normal-appearing skin around tumor
For locally advanced disease (T3-T4): 3
- Partial amputation is standard of care for T3 with corpora cavernosa involvement
- Induction chemotherapy for non-resectable tumors (57% objective response rate with taxane-platinum combinations)
Critical Pitfalls to Avoid
Do not assume vitiligo: While vitiligo causes hypopigmentation, it doesn't cause architectural changes and is asymptomatic—LS causes pruritus and structural changes 2
Do not delay biopsy: The risk of malignancy in untreated or poorly controlled LS necessitates tissue diagnosis when there's a concerning lesion 2
Do not miss superimposed infections: Check for herpes simplex, candidiasis, or contact allergy if treatment fails 2
Do not ignore urethral involvement: 10-20% of male LS patients develop urethral disease, which can progress from meatal to panurethral involvement 2. Early treatment of meatal disease may prevent urethral strictures 2
Follow-up Requirements
If benign LS is confirmed and responds to treatment, follow-up at 3 months to assess response, then at 6 months before potential discharge 2. However, any patient with a severe or atypical lesion requires long-term specialist follow-up to monitor for malignant transformation 2.
The patient must be instructed to report immediately: new areas of erosion, ulceration, lumps, lack of response to treatment, or change in symptoms 2.